Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.

Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.

Item
http://www.wikidata.org/entity/Q34646022
Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndromeDual antiplatelet therapy: optimal timing, management, and durationThienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysisAn agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.Causes of late mortality with dual antiplatelet therapy after coronary stents.International patterns of dual antiplatelet therapy duration after acute coronary syndromes.Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting.Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.Structure-activity relationship studies for multitarget antithrombotic drugs.Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes.Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation.Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation.Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation.
P2860

Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.

Item
http://www.wikidata.org/entity/Q34646022
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@ast
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@en
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@nl
type
label
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@ast
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@en
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@nl
prefLabel
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@ast
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@en
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Benefit of long-term dual anti ...... om the NHLBI dynamic registry.
@en
P2093
P2860
P304
P31
P356
10.1016/J.AMJCARD.2012.10.030
P407
P433
P478
P577
P698
P932